Anne Wofford is an Oncology physician affiliated with Atrium Health Wake Forest Baptist. OpenAlex indexes 13 publications with 214 citations (h-index 2); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Medical Center Blvd
Winston Salem, NC 271570001
Telephone
336-716-3305Provider last certified this registry record 10 Aug 2022.
Clinical trials
- Comprehensive Care for AYA: Needs Assessment Survey
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20252 payments
- Adaptive Biotechnologies CorporationProgram year20251 payment
- Autolus IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30.2%Calcineurin inhibitor30.2%Cyclosporine Modified100%Part D<11 patientsBlood & clotting
27%Thrombopoietin Receptor Agonist27%Promacta100%Part D<11 patientsDermatology
23.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor23.8%Acyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- An Evaluation of the Impact of Cachexia on Transplant Outcomes
Biology of Blood and Marrow Transplantation
2026 - Barriers to Allogeneic Stem Cell Transplant in Patients with Malignant and Non-Malignant Hematologic Conditions
Biology of Blood and Marrow Transplantation
2025 - Riding the Wave: Risk Factors for Acute Kidney Injury in Patients Receiving Ptcy with Hyperhydration
Biology of Blood and Marrow Transplantation
2024 - Haploidentical Transplant Using a Novel Preparative Regimen: An Update on a New Standard of Care for Patients without HLA Matched Donors
Biology of Blood and Marrow Transplantation
2023
Similar KOLs
Other experts from the same institution or the same specialty.
David Herrington, MD
Atrium Health Wake Forest Baptist
Bruce Lessey, MD
Atrium Health Wake Forest Baptist
David Hurd, MD
Atrium Health Wake Forest Baptist
Kevin High, MD
Atrium Health Wake Forest Baptist
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”